Demise threats. Cyber harassment. Profession dangers.
Calling out issues with COVID science in a politically charged pandemic comes at a price.
However that will not cease these three scientists — together with a physician who heads a COVID-19 ward in a Paris hospital.
They need science to do higher.
Particularly when it could possibly make the distinction between life and demise.
However why does interrogating the standard of analysis include such private threat?
Friends:
Dr Lonni Besancon
@lonnibesancon
Postdoctoral fellow
Division of Human Centred Computing
Monash College, Australia
Gideon Meyerowitz-Katz
@healthnerd
Epidemiologist, science communicator, and host of Sensationalist Science podcast (SenseSciPod)
College of Wollongong
Dr Nathan Peiffer-Smadja
@nathanpsmad
Infectious illnesses doctor
Head of Infectious Illnesses Clinic
Hôpital Bichat – Claude-Bernard AP-HP (Paris)
Researcher
Nationwide Institute for Well being and Medical Analysis, France
and Imperial School London
Additional data:
Open Science Saves Lives: Lessons from the COVID-19 Pandemic (pre-print as of Might 2020))
Hydroxychloroquine and COVID-19: a tale of populism and obscurantism (Peiffer-Smadja et al)
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis (Peiffer-Smadja et al)
Responses to Gautret et al. paper
Commentary by Dr Elisabeth Bik, 2020 on Gautret et al. paper about Hydroxychloroquine and Azithromycin therapy of COVID-19 infections
Pubpeer commentary on Gautret et al paper
Official Statement from International Society of Antimicrobial Chemotherapy, 2020
Recovery Trial (Randomised Evaluation of COVID-19 therapy) conclusion on hydroxychloroquine, 2020
Assessing mandatory stay‐at‐home and business closure effects on the spread of COVID‐19
Sample size, timing, and other confounding factors: towards a fair assessment of stay-at-home orders
Articles in The Gaurdian by Gideon Meyerowitz-Katz
